<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04456751</url>
  </required_header>
  <id_info>
    <org_study_id>CHUB_redoped</org_study_id>
    <nct_id>NCT04456751</nct_id>
  </id_info>
  <brief_title>Is Redo Pediatric Cardiac Surgery a Risk Factor for Transfusion?</brief_title>
  <official_title>Is a Reintervention for Pediatric Cardiac Surgery Associated With Higher Blood Transfusion Requirements ?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Brugmann University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Brugmann University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In pediatric cardiac surgery, transfusion requirements are associated with age, development
      status, pathology, type of surgical intervention and extracorporeal bypass. In adult cardiac
      surgery, reinterventions (redo)are clearly linked to higher transfusion rates. The
      investigators want to study if this association is also true in pediatric cardiac surgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Whereas in adult cardiac surgery, redo-interventions are clearly linked to a higher
      transfusion rate, this is not really known in paediatric cardiac surgery. In this
      retrospective study, the investigators will analyse our database for paediatric cardiac
      surgery patients aged 0-16 years and operated between 2002 and 2017. Patients with a single
      cardiac surgery will be compared to patients with a second cardiac operation under
      extracorporeal bypass. The investigators will test the variables for normal distribution
      using a Shapiro-Wilk test. Non normal distributed variables will be compared by a
      non-parametric test (Mann Whitney U), frequency analysis will be done by a Chi-Square test. A
      univariate analysis will determine predicting factors for transfusion. Factors with a P value
      &lt; 0.1 will be analysed by a multivariate analysis to determine independent factors for
      transfusion. Odds with 95% confidence intervals will be calculated. A P value &lt; 0.05 will be
      considered statistically significant.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 2, 2020</start_date>
  <completion_date type="Anticipated">August 15, 2020</completion_date>
  <primary_completion_date type="Anticipated">August 15, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Transfusion of packed red cells (mL/kg)</measure>
    <time_frame>Day of operation up to 5 days postop</time_frame>
    <description>Transfusion requirements will be measured as volume of packed red cells given as mL packed red cells/kg of body weight</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">2500</enrollment>
  <condition>Pediatric Cardiac Surgery</condition>
  <condition>Transfusion</condition>
  <arm_group>
    <arm_group_label>No redo op</arm_group_label>
    <description>Patients with a single cardiac operation under extracorporeal bypass</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Redo op</arm_group_label>
    <description>Patients with a redo cardiac operation under extracorporeal bypass</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Redo op</intervention_name>
    <description>Patients with a redo operation</description>
    <arm_group_label>Redo op</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All patients between 0 and 16 years undergoing cardiac surgery with cardiopulmonary bypass
        in our institution. We will exclude Jehovah's witness patient as they refuse a transfusion.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients between 0 and 16 years

          -  Cardiac surgery with cardiopulmonary bypass

        Exclusion Criteria:

          -  Jehova's witness
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>16 Years</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Denis Schmartz, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU Brugmann</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Denis Schmartz, MD</last_name>
    <phone>3224773996</phone>
    <email>denis.schmartz@chu-brugmann.be</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Philippe Van Der Linden, MD</last_name>
    <phone>3224773996</phone>
    <email>philippe.vanderlinden@chu-brugmann.be</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>HÃ´pital Universitaire des Enfants Reine Fabiola</name>
      <address>
        <city>Brussels</city>
        <zip>1020</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Denis Schmartz, MD</last_name>
      <phone>+3224773996</phone>
      <email>denis.schmartz@chu-brugmann.be</email>
    </contact>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>June 25, 2020</study_first_submitted>
  <study_first_submitted_qc>June 30, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">July 2, 2020</study_first_posted>
  <last_update_submitted>July 2, 2020</last_update_submitted>
  <last_update_submitted_qc>July 2, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 7, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Brugmann University Hospital</investigator_affiliation>
    <investigator_full_name>Denis SCHMARTZ</investigator_full_name>
    <investigator_title>Head of Anesthesiology department</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

